A part of Watch Media

MedWatchSunday5 February 2023

  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
30/08/2022at 12:36

GN has yet to feel impact of new Chinese lockdowns

A new round of Chinese Covid-19 restrictions have not threatened the Danish hearing aid manufacturer’s production in the country – the situation is being closely monitored, however.
GN Hearing has manufacturing in Xiamen, China | Photo: PR
by marketwire, translated by daniel pedersen

On Tuesday, China ramped up its efforts to curb Covid-19 in a number of large cities as cases were confirmed.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters

Get full access for you and your coworkers

Start a free company trial today

Related articles:

  • Gitte Aabo, CEO of GN Hearing | Photo: GN Store Nord / PR

    China's hard line on Covid-19 won't hinder GN Hearing – workers can isolate in factories

    For subscribers

  • Photo: Sonova / PR

    Sonova acquires Chinese hearing clinics chain

    For subscribers

  • Søren Nielsen, CEO of Demant | Photo: Kenneth Lysbjerg Koustrup/Jyllands-Posten/Ritzau Scanpix

    Demant plans to increase investments in China

    For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Nu mangler kun en endelig vedtagelse i EU-Parlamentet, før lovforslag om at udskyde deadlines for nye krav til medicinsk udstyr. er en realitet. | Foto: Thomas Borberg/Ritzau Scanpix
Medtech

Another hurdle overcome in delaying MDR deadline

EU member countries have voted unanimously to adopt an EU Commission proposal to stagger the implementation of the new Medical Device Regulation. Now, only the EU Parliament’s vote remains. 
  • Asensus Surgical wins CE Mark for intelligent surgical unit under MDR rules
  • EU Commission to give more time for MDR transition

For subscribers

Foto: Stine Tidsvilde
Pharma & biotech

Novo Nordisk hopes to retain employees with share gift

For subscribers

Foto: MedWatch
Other

Top news from MedWatch this week

Luja can potentially solve a long-lived UTI problem for people who need help with bladder control issues by using new micro-hole technology
Medtech

Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps

For subscribers

Foto: Coloplast/pr
Medtech

Coloplast launches male catheter featuring new technology

For subscribers

Foto: Coloplast / Pr
Medtech

Coloplast's bottom line disappoints in otherwise strong report

For subscribers

Further reading

Photo: Magnus Møller
Pharma & biotech

Extensive layoffs at Leo Pharma – 300 jobs lost

On Thursday, Leo Pharma executed a firing round among employees primarily at the company’s R&D division. 

For subscribers

Tobias S. Christensen (right) took up the CEO mantle from his father, Lars Christensen (left) in summer of last year | Foto: Pharmacosmos / Pr
Pharma & biotech

Pharmacosmos to invest in Chinese organization following reimbursement win

The Danish company is the first in China to receive reimbursement approval for a high-dose iron deficiency drug, says Pharmacosmos CEO Tobias Christensen – but the competition is hot on their heels.

For subscribers

Pharmacosmos is located in Danish town Holbæk, and employs approximately 500 people in total | Foto: Pharmacosmos / Pr
Pharma & biotech

Pharmacosmos wins Chinese reimbursement deal

The Chinese health agency, NHSA, has granted Pharmacosmos’s intravenous iron treatment, Monofor, national reimbursement in China – one of the largest iron deficiency markets in the world.

For subscribers

Latest news

  • Top news from MedWatch this week – 3 Feb
  • Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps – 3 Feb
  • China accepts regulatory filing for ALK allergy tablet – 3 Feb
  • Another hurdle overcome in delaying MDR deadline – 3 Feb
  • Dupixent becomes ninefold blockbuster – 3 Feb
  • ALK forecasts lower growth in 2023 than strong 2022 result – 3 Feb
  • Unilabs and Siemens Healthineers enter million-euro strategic partnership – 3 Feb
  • Coloplast launches male catheter featuring new technology – 3 Feb
  • Novo Nordisk hopes to retain employees with share gift – 3 Feb
  • Coloplast's bottom line disappoints in otherwise strong report – 3 Feb
See all

Jobs

  • Commercial Director

  • Supply Chain Manager

  • Clinical Operational Associate

  • Lead Data Architect

  • Medical Advisor (Metabolism)

  • Senior Clinical Project Manager

  • Sr. Director, Drug Safety Physician

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Application Manager

  • Application Manager

  • Experienced Patent Counsel

  • Regulatory Affairs Professional

  • Senior Health Economics and Outcomes Research (HEOR) Manager

See all jobs

Jobs

  • Commercial Director

  • Supply Chain Manager

  • Clinical Operational Associate

  • Lead Data Architect

  • Medical Advisor (Metabolism)

  • Senior Clinical Project Manager

  • Sr. Director, Drug Safety Physician

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Application Manager

  • Application Manager

  • Experienced Patent Counsel

  • Regulatory Affairs Professional

  • Senior Health Economics and Outcomes Research (HEOR) Manager

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved

Microsoft is in the process of discontinuing Internet Explorer – and so are we.
For a better experience, we recommend using one of the following browsers.

Kind regards,
MedWatch

Google ChromeMozilla FirefoxMicrosoft Edge